Acute Abdomen as a Clinical Presentation of COVID-19-Associated Multisystem Inflammatory Syndrome in Children.
Elmira Hajiesmaeil MemarFatemeh TahghighiSedigheh YousefzadeganParisa SadeghiradAshraf MousaviRamin Zare MahmoudabadiHossein SaeidiMehri AyatiSahar NaderiSara MemarianSeyedmusa ZeinalabedinBahar AshjaeiHojatollah RajiLeila TaherniaHosein AlimadadiVahid ZiaeePublished in: Case reports in surgery (2024)
Patients experiencing unexplained acute abdominal pain along with fever, skin rash, and peripheral edema, who had a history of COVID-19 infection prior to or during the episode of acute abdomen symptoms, should be considered to have MIS-C. Furthermore, methylprednisolone pulse therapy could be a safe treatment option, reducing hospitalization duration in this patient population.
Keyphrases
- liver failure
- respiratory failure
- aortic dissection
- end stage renal disease
- abdominal pain
- drug induced
- coronavirus disease
- case report
- newly diagnosed
- ejection fraction
- oxidative stress
- young adults
- blood pressure
- peritoneal dialysis
- prognostic factors
- low dose
- intensive care unit
- extracorporeal membrane oxygenation
- mesenchymal stem cells
- combination therapy
- depressive symptoms
- soft tissue
- cell therapy
- wound healing